First-in-human trial shows B7-H4 antibody-drug conjugate shrinks ovarian, endometrial and breast tumors
A first-in-human Phase 1/2a trial of the B7-H4-targeting antibody-drug conjugate puxitatug samrotecan reported partial responses in heavily pretreated ovarian, endometrial ...
